Thu, April 22, 2021
Wed, April 21, 2021
Tue, April 20, 2021
Mon, April 19, 2021
Fri, April 16, 2021
Thu, April 15, 2021

Matthew Harrison Maintained (BMRN) at Hold with Decreased Target to $82 on, Apr 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-82-on-apr-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Decreased Target from $85 to $82 on, Apr 19th, 2021.

Matthew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, March 1st, 2021
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $91 on, Monday, March 1st, 2021

Publication Contributing Sources